(157 days)
UltraFlex™ IAB with Intra-Aortic Balloon Pump as a control system is indicated for use in any of the following conditions:
-
Acute Coronary Syndrome
-
Cardiac and Non-Cardiac Surgery
-
Complications of Heart Failure
The UltraFlex IAB consists of an inflatable balloon, which is placed in the aorta to improve cardiovascular functioning. A computerized control system, also known as Intra-Aortic Balloon Pump (IABP) regulates the inflation and deflation of the balloon.
The UltraFlex IAB catheter consists of an inner lumen, an outer lumen, and an inflatable balloon. The outer lumen is comprised of an inflatable balloon connected to the distal tip of the catheter shaft and to the IAB catheter tip outer surface. The inner lumen is comprised of a luer adapter connected to the proximal end of the inner lumen and to the IAB catheter tip inner surface.
The provided text is a 510(k) summary for the UltraFlex™ IAB, an intra-aortic balloon catheter. This document describes the device, its indications for use, and a comparison to a predicate device. It also mentions various bench tests conducted to demonstrate substantial equivalence, but it does not contain information about a study proving the device meets acceptance criteria using a test set with expert adjudicated ground truth, multi-reader multi-case studies, or information about training sets and their ground truth establishment.
Therefore, I cannot fulfill the request to describe the acceptance criteria and the study that proves the device meets the acceptance criteria by extracting information from the given text.
The closest relevant information extracted is:
Acceptance Criteria Mentioned (but specific values are not provided):
- The results of the verification tests met the specified acceptance criteria and performed similar to the predicate device.
Study Type (Bench Tests, not clinical or image-based AI performance studies):
The document states that technological differences have been evaluated through bench tests. The following tests were performed:
- Catheter Insertion Test
- Aneurysm Test
- Durability Test
- Catheter Tip to Balloon Bond Tensile per ISO 10555-1
- Outer Lumen to Balloon Bond Tensile per ISO 10555-1
- Sheath and Dilator Surface Visual Inspection per ISO 11070
- Sheath and Dilator Tensile Testing per ISO 11070
- Balloon Volume Test
- Catheter Rate Limit Test
- Kink Resistance
- Sheath and Dilator Dimensional Analysis
Data Provenance/Sample Size (Not Applicable in the provided text for a clinical test set):
The document does not describe a clinical test set, nor does it specify sample sizes for the bench tests.
Experts, Adjudication, MRMC, Standalone Performance, Ground Truth Type, Training Set Details (Not Applicable/Not Present in the provided text):
The 510(k) summary focuses on demonstrating substantial equivalence based on bench testing of physical and functional characteristics of the device compared to a predicate device, not on diagnostic performance or AI algorithm validation using image data, which would typically involve expert readers, ground truth establishment, and MRMC studies. Therefore, the requested details about expert qualifications, adjudication methods, MRMC studies, standalone performance, training sets, and ground truth establishment methods for training sets are not present in this document.
§ 870.3535 Intra-aortic balloon and control system.
(a)
Identification. An intra-aortic balloon and control system is a prescription device that consists of an inflatable balloon, which is placed in the aorta to improve cardiovascular functioning during certain life-threatening emergencies, and a control system for regulating the inflation and deflation of the balloon. The control system, which monitors and is synchronized with the electrocardiogram, provides a means for setting the inflation and deflation of the balloon with the cardiac cycle.(b)
Classification. (1) Class II (special controls) when the device is indicated for acute coronary syndrome, cardiac and non-cardiac surgery, or complications of heart failure. The special controls for this device are:(i) Appropriate analysis and non-clinical testing must be conducted to validate electromagnetic compatibility and electrical safety of the device;
(ii) Software verification, validation, and hazard analysis must be performed;
(iii) The device must be demonstrated to be biocompatible;
(iv) Sterility and shelf-life testing must demonstrate the sterility of patient-contacting components and the shelf life of these components;
(v) Non-clinical performance evaluation of the device must demonstrate mechanical integrity, durability, and reliability to support its intended purpose; and
(vi) Labeling must include a detailed summary of the device- and procedure-related complications pertinent to use of the device.
(2) Class III (premarket approval) when the device is indicated for septic shock and pulsatile flow generation.
(c)
Date premarket approval application (PMA) or notice of completion of product development protocol (PDP) is required. A PMA or notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before March 31, 2014, for any intra-aortic balloon and control system indicated for septic shock or pulsatile flow generation that was in commercial distribution before May 28, 1976, or that has, on or before March 31, 2014, been found to be substantially equivalent to any intra-aortic balloon and control system indicated for septic shock or pulsatile flow generation that was in commercial distribution before May 28, 1976. Any other intra-aortic balloon and control system indicated for septic shock or pulsatile flow generation shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.